Federal contract award

75A50324C00006

ANTHIM (OBILTOXAXIMAB)

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeASPR/ORM-SNS
NAICS325412 — Pharmaceutical Preparation Manufacturing
PSC6505 — Drugs and Biologicals
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIRM FIXED PRICE
Obligations$124.5M
Current contract value$124.5M
Potential contract value / ceiling$124.5M
Start dateMay 1, 2024
Current end dateDec 31, 2028
Potential end dateDec 31, 2028
Latest award activityJul 7, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 8 of 8 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Jul 7, 2026P00007$9.6MADMINISTRATIVE OBJECT CLASS CODE CORRECTION-ANTHIM (OBILTOXAXIMAB)
Jun 1, 2026P00006$-9.6MADMINISTRATIVE OBJECT CLASS CODE DEOBLIGATION-ANTHIM (OBILTOXAXIMAB)
Jan 21, 2026P00005$0ANTHIM (OBILTOXAXIMAB)
Aug 22, 2025P00004$55.3MANTHIM (OBILTOXAXIMAB)
Jul 23, 2025P00003$0ANTHIM - ASSIGNMENT OF CLAIMS
May 14, 2024P00002$55.1MANTHIM - RE-OBLIGATE FUNDS TO REALIGN OC
May 10, 2024P00001$-55.1MDE-OBLIGATE FUNDS FROM CLIN 0001 AND 0004 TO REALIGN OBJECT CLASS CODES
Apr 30, 20240$69.3MANTHIM (OBILTOXAXIMAB)

Estimated positioning window

Dec 31, 2027 – Jun 30, 2028

Recompete signal:
50/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 50/100. Available recorded signals: 45 points.

Contract end 2028-12-31 (791 days from calculation)
+15 points
31 historical awards in this buyer and category group
+15 points
8 recorded award transactions
+10 points
Latest award action: 2026-07-07
+5 points
Parent award identifier recorded
+0 points
Solicitation identifier recorded
+0 points
Linked official forecast
+0 points
Calculated on
2026-11-01 10:17:53.997580+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Nov 1, 2026.

Research next steps

  1. Check the linked forecast or SAM for a confirmed solicitation and current timing.
  2. Check the stated set-aside against the solicitation and current certifications.
  3. Review the award scope and buyer evidence before making a bid/no-bid decision.